Article Text

other Versions

Download PDFPDF
COVID-19: gynecologic cancer surgery at a single center in Madrid
  1. Javier de Santiago1,
  2. Carmen Yelo1,
  3. Maria F Chereguini1,
  4. Ana Conde1,
  5. Javier Galipienzo2,
  6. David Salvatierra2,
  7. Manuel Linero2 and
  8. Sonsoles Alonso1
  1. 1 Gynecology, MD Anderson Cancer Center Madrid, Madrid, Spain
  2. 2 Anesthesiology, MD Anderson Cancer Center Madrid, Madrid, Spain
  1. Correspondence to Carmen Yelo, Gynecology, MD Anderson Cancer Center Madrid, Madrid 28033, Spain; cyelo{at}


Objectives While numerous medical facilities have been forced to suspend oncological surgery due to system overload, debate has emerged on using non-surgical options on cancer cases during the pandemic. The goal of our study was to analyze, in a retrospective cohort study, the results of gynecological cancer surgery and evaluate postoperative complications in a single center in one of the most affected areas in Europe.

Methods We retrospectively analyzed the records of patients who were referred between March 2020 and May 2020 for primary surgical treatment of breast, endometrial, ovarian, cervical, or vulvar cancer.

Results The study included a total of 126 patients. Median age was 60 years (range 29–89). Patients were referred with breast (76/126, 60.3%), endometrial (29/126, 23%), ovarian (14/126, 11.1%), cervical (5/126, 4%), or vulvar cancer (2/126, 1.6%). Polymerase chain reaction (PCR) test for detection of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was only conducted in 50% of cases due to the low availability of tests during the first phase of our study, and was indicated only in suspected cases according to the healthcare authorities' protocol. Median hospital stay was 1 day (range 0–18). Excluding breast surgery, laparoscopy was the most used procedure (43/126, 34.1%). 15 patients had a postoperative complication (15/126, 11.9%); only in 2 patients (2/15 13.3%) were there reports of Clavien–Dindo grade 3 or 4 complications. 6 patients tested positive for COVID-19 following a PCR diagnostic test, and these surgeries were cancelled.

Conclusions Adequate protective measures in the setting of COVID-19 free institutions enabled the continuity of cancer surgery without significant compromise of the safety of patients or healthcare workers.

  • surgery
  • gynecologic surgical procedures
  • surgical oncology
  • postoperative complications
  • laparoscopes

This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors JdS conducted the study which was planned and reported by the gynecologic, oncology, and anesthesia team (authors listed), who were involved in the surgical procedures.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The study was reviewed and approved by the medical ethical committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available upon reasonable request. The data generated by our research is openly and publicly available upon publication of the article.